Last reviewed · How we verify
NCT05530109: ATTENTIONEPIG
Study of Attentional Disorders in Patients Suffering From Idiopathic Generalized Epilepsy.
trial testing Neuropsychological screening and high resolution EEG recording in Idiopathic Generalized Epilepsy in 33 participants. Terminated before completion.
25 April 2025
Quick facts
| Lead sponsor | University Hospital, Lille |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 33 |
| Start date | 26 April 2022 |
| Primary completion | 25 April 2025 |
| Estimated completion | 25 April 2025 |
| Sites | 1 location across France |
Drugs / interventions tested
- Neuropsychological screening and high resolution EEG recording
Conditions studied
- Idiopathic Generalized Epilepsy — all drugs for Idiopathic Generalized Epilepsy →
Sponsor
University Hospital, Lille
Who can join
Adults 18 to 65, any sex, with Idiopathic Generalized Epilepsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Attentional disorders have been reported in neuropsychological studies evaluating patients suffering from generalized idiopathic epilepsy, but the data are disparate (in terms of test protocol). We aim to describe attentional and executive function disorder in IGE thanks to the Epitrack scale, validated in this specific population. Our secondary objective is to study the dynamic of cortical activity during an attentional task (the ANT), in order to describe the alteration of cortical networks in epileptic patients presenting with attentional disturbance.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05530109
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital, Lille trials
Trials by the same sponsor.
- NCT07528664 — Assessement of a Test a Financial-incentive Program for Pregnant Women and Their Smoking Partners to Reduce Smoking Duri · NA · not yet recruiting
- NCT07434739 — PAravertebral CaTheter Versus Epidural Analgesia in Totally Minimally Invasive Esophagectomies · NA · not yet recruiting
- NCT06958224 — Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers · NA · not yet recruiting
- NCT07408999 — Totally Versus Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer · NA · not yet recruiting
- NCT07492030 — Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05530109 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Lille
- Last refreshed: 15 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05530109.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing